We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Aurinia Selects Worldwide As CRO For Phase3 Valcosporin Trial

News   Jan 31, 2017 | Original Story From Aurinia Pharmaceuticals

 
Aurinia Selects Worldwide As CRO For Phase3 Valcosporin Trial
 
 
 

RELATED ARTICLES

Stem Cells Grown in Media Free of Animal-derived Compounds

News

Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds, a requirement for therapeutic applications.

READ MORE

New Role for Microvessels in Spinal Cord Injury

News

Previously unidentified roles have been established for endothelial cells: they engulf myelin debris following spinal cord injury, and contribute to the progression of inflammation, angiogenesis, and possibly, fibrotic scar formation.

READ MORE

Is Malaria Eradication in Sight?

News

Changes in mosquito behavior and selection in the parasites mean new strategies are needed for any hopes of eradicating the disease following stalling of the positive trend in 2015.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE